Form 4: Mural Oncology CEO Sells Shares to Cover Tax Obligations

Caroline Loew, CEO of Mural Oncology plc, sold 12,531 ordinary shares on July 8, 2024, to satisfy tax withholding obligations related to vesting restricted stock units.

Summary

• On July 8, 2024, Caroline Loew, the CEO of Mural Oncology plc, sold 12,531 ordinary shares.
• The shares were sold at a weighted average price of $2.91, with individual transactions ranging from $2.91 to $2.93.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units granted on December 14, 2023.
• This transaction was conducted under a pre-arranged plan (Rule 10b5-1) established on March 27, 2024, and does not represent a discretionary trade by the CEO.
• Following the transaction, Loew directly owns 240,391 ordinary shares.

Sentiment

Score: 6

Explanation: The document reflects a routine transaction (sale of shares for tax obligations) and doesn't indicate any significant positive or negative sentiment. The use of a pre-arranged trading plan suggests transparency and avoids concerns about insider trading.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among company executives and are generally viewed as routine transactions.

Stakeholder Impact

• The sale of shares by the CEO could have a minor impact on shareholder sentiment, but is unlikely to be significant given the routine nature of the transaction.

Key Dates